Roughly 2 years postsurgery, objective parameters for esophageal emptying via timed barium esophagram in patients who received per-oral endoscopic myotomy returned to presurgery levels, or worse.
Compared with proton pump inhibitor (PPI) therapy, magnetic sphincter augmentation (MSA) was far superior for reducing regurgitation in regurgitative gastroesophageal reflux disease (GERD), and relief is sustained over 12 months.
In most cases of diagnostic esophagogastroduodenoscopy (EGD) performed for refractory gastro-esophageal reflux disease (GERD), symptoms alone did not result in pathological findings that prompted a change in the patient’s GERD management.
Eosinophilic esophagitis (EoE) is a clinicopathologic disease for which proton pump inhibitors (PPIs) are now considered a treatment option. Of children with EoE, 32% responded to high-dose proton pump inhibitor (HDPPI) therapy.
EoE activity rapidly recurred after initial response to oral viscous budesonide (OVB) or fluticasone from a multidose inhaler (MDI), indicating the need for maintenance therapy for patients who achieve histologic response to topical steroids.
CVS is the latest drugstore chain to stop selling over-the-counter Zantac (ranitidine), as well as the store’s own generic version of the heartburn medicine, because of contamination with a known carcinogen.
Novartis, the maker of a generic form of Zantac, said Wednesday it will cease distribution of the medicine after investigations suggested that generic and branded versions contain a known carcinogen.
Because of the tolerability and enhanced effectiveness of P-CABs, it is very likely that they will change the future of treatment of acid-related disorders.
A substance that could cause cancer has been found in some ranitidine heartburn and ulcer medicines, including the brand-name drug Zantac, and the source of this contamination is being investigated.
Using an ELISA model, researchers have confirmed the high sensitivity and specificity of the monoclonal antibody Das-1 in detecting pancreatic cystic lesions (PCLs) with a risk for malignancy.
Although the results of ESD were generally positive in managing Barrett’s neoplasia, procedural improvements are needed ESD is to replace piecemeal endoscopic mucosal resection.
Repeat per-oral endoscopic myotomy (POEM) procedures are safe and efficacious for patients with persistent symptoms following initial POEM in the management of achalasia.
Of the roughly two-thirds of reports of swallowing problems that included age data, more than three-quarters (76.8 percent) involved adults aged 65 years or older.
A working group of 35 international experts released the ICARUS guidelines on the selection of patients with gastroesophageal reflux disease for antireflux surgery.
